The FarmaMondo Group, leveraging its geographical footprint and infrastructure, provide complimentary access services for licensed commercial medicines through in-licensing and partnership agreements with pharmaceutical manufacturers and biotech. Alongside our unlicensed medicines operations the Group market access and distribution capabilities allow greater life cycle management of therapies through commercial launching in several of the most promising geographies of the globe.
In cases where the supply options of a therapy on an unlicensed basis may be limited or inexistent, FarmaMondo can support manufacturers of specialty medicines with commercial potential, in transitioning their therapies from unlicensed to a licensed status, helping to further address unmet medical need and capitalize on the drug potential through an all-inclusive commercial launch plan.
The Group offers market access services for commercial medicines and transition services from Unlicensed to Licensed, in Switzerland, Russia and CIS region, including Ukraine and Baltics, Nordic region and in certain countries in Latin America. Service package typically include Regulatory, Marketing and Sales, Distribution, Pricing and reimbursement, Market Access.
We are constantly looking for pharmaceutical and biotech companies who seek to partner with FarmaMondo to develop, license and commercialize medicines within our international market access and distribution infrastructure.